CYTOPENIA
Clinical trials for CYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CYTOPENIA trials appear
Sign up with your email to follow new studies for CYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could early treatment stop a Pre-Cancer blood condition?
Disease control Recruiting nowThis study looks at whether giving an oral drug early to people with a high-risk blood condition called CCUS is safe and practical. CCUS can sometimes turn into blood cancer, and currently there is no standard treatment. Participants can choose to take the drug or just be watched…
Matched conditions: CYTOPENIA
Phase: EARLY_PHASE1 • Sponsor: Lachelle D. Weeks, MD, PhD • Aim: Disease control
Last updated May 17, 2026 04:10 UTC
-
New hope for low blood counts after CAR T-Cell therapy
Disease control Recruiting nowThis study tests a drug called emapalumab to see if it can safely help people with lymphoma recover from dangerously low blood cell counts that persist after CAR T-cell therapy. About 32 adults whose blood counts have not improved after standard CAR T treatment will receive emapa…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:10 UTC
-
New hope for anemia in MDS: experimental drug enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called elritercept (KER-050) in about 160 adults with a bone marrow condition called myelodysplastic syndromes (MDS) who have anemia. The main goal is to check the drug's safety and how well people tolerate different doses. Researchers will a…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Early drug may boost blood cell recovery in kids with rare bone marrow failure
Disease control Recruiting nowThis study tests whether giving emapalumab early, right after diagnosis, can improve blood cell recovery in children with severe aplastic anemia. About 35 children will receive the drug to see if it helps standard treatments work better. The goal is to improve blood counts within…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Blood test may end painful bone marrow biopsies for MDS patients
Diagnosis Recruiting nowThis study aims to develop a new blood test to diagnose a bone marrow disorder called MDS, potentially replacing the need for a painful bone marrow biopsy. Researchers will collect blood samples from 1500 adults with low blood cell counts to see if the test can accurately detect …
Matched conditions: CYTOPENIA
Sponsor: Weizmann Institute of Science • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC
-
Can a simple genetic test catch blood cancers before they start?
Knowledge-focused Recruiting nowThis study uses advanced genetic testing (next generation sequencing) to look for early warning signs of pre-myeloid cancers and bone marrow failure in 2000 people. Participants have certain blood abnormalities or genetic markers that may increase their risk. The goal is to bette…
Matched conditions: CYTOPENIA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 04:09 UTC